Presentation TVT 2017 Who Shouldnt Undergo TAVR? Can We Identify Non-responders? Presenter: Suzanne V. Arnold June 16, 2017 REGISTER for free or LOG IN to view this content Aortic Valve Presentation TVT 2017 TAVR Up Next Presentation TVT 2017 Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results Presenter: Ran Kornowski June 16, 2017 More slides + Presentation TVT 2017 TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples Presenter: Nir Uriel June 16, 2017 Presentation TVT 2017 Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors Presenter: Adam Castano June 16, 2017 We Recommend
Presentation TVT 2017 Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results Presenter: Ran Kornowski June 16, 2017
Presentation TVT 2017 TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples Presenter: Nir Uriel June 16, 2017
Presentation TVT 2017 Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors Presenter: Adam Castano June 16, 2017